CD20L (MS4A3) antibodies, human

CD20L (MS4A3) antibodies, human

Clone: REA756 | Dilution: 1:50
Clone REA756 recognizes the human CD20L, an intracytoplasmic membrane protein, which is also known as Htm4 or MS4A3. It is present specifically in hematopoietic cells and tissues. CD20L functions as a hematopoietic modulator for the G1-S cell cycle transition. It binds to cyclin-dependent kinase inhibitor 3 (CDKN3/KAP) and modulates the level of phosphorylation of cyclin-dependent kinase 2 (CDK2).
Additional information: Clone REA756 displays negligible binding to Fc receptors.

Alternative names

CD20L, HTM4

Technical specifications

  • Antigen: CD20L (MS4A3)
  • Clone: REA756
  • Isotype: recombinant human IgG1
  • Isotype control: REA Control (I) antibodies
  • Alternative names of antigen: CD20L, HTM4
  • Entrez Gene ID: 932
  • Molecular mass of antigen [kDa]: 23
  • Distribution of antigen: hematopoietic cells
  • Product format: Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.
  • Fixation: The antibody is suited for staining of formaldehyde-fixed cells.
  • Storage: Store protected from light at 2–8 °C. Do not freeze.
  • Available conjugates: PE, APC, PE-Vio770
  • Selected references

    1. Donato, J. L. et al. (2002) Human HTm4 is a hematopoietic cell cycle regulator. J. Clin. Invest. 109(1): 51-58
    2. Chinami, M. et al. (2005) Binding of HTm4 to cyclin-dependent kinase (Cdk)-associated phosphatase (KAP).Cdk2.cyclin A complex enhances the phosphatase activity of KAP, dissociates cyclin A, and facilitates KAP dephosphorylation of Cdk2. J. Biol. Chem. 280(17): 17235-17242
Product options: 6
for 30
tests
(1)
JPY 26,000
for 100
tests
(1)
JPY 62,000
for 30
tests
(1)
JPY 26,000
for 100
tests
(1)
JPY 62,000
for 30
tests
(1)
JPY 25,000
for 100
tests
(1)
JPY 59,000

Related products

4 products available